Dantrolene Sodium

丹曲林钠

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameDantrolene Sodium
Drug Alias NameDantrolenum丹屈林钠Dantroleno硝苯呋海因钠DANTRIUM IV +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHeat StrokeFeverMalignant Hyperthermia +[12] 
Global Approved IndicationsMalignant HyperthermiaSpasm
Approved Indications in ChinaMalignant HyperthermiaSpasm
Original Approved Country/TerritoryUnited States
Original Approved Date1974/01/15
Country/TerritoryUnited StatesSaudi ArabiaAustria +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNorgine Europe BvEndo International Plc
China Registration ClassN/A

Develop Information

Active CompaniesPH Health LtdNorgine BVWashington University School Of Medicine +[6] 
Inactive CompaniesEagle Pharmaceuticals IncUniversity Of Massachusetts Medical SchoolMedical University Of Vienna +[5] 
Active IndicationsMalignant HyperthermiaDiabetes MellitusTachycardia, Ventricular +[8] 
Inactive IndicationsHeat StrokeFeverVasospasm, Intracranial +[4] 

Other Information

ATC CodeM03CA01
Related LinksWikipediaDrugBankKEGG